| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.19 | 1e-08 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.27 | 3e-06 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-06 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.17 | 7e-06 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.18 | 9e-06 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.15 | 5e-05 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-05 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.29 | 0.0001 |